Impact of Anticholinergic Medication Burden on MMN and P3a in Schizophrenia

被引：0
|
作者：
Joshi, Yash [1 ]
Miyakoshi, Makoto [2 ]
Molina, Juan [1 ]
MacDonald, Laura [1 ]
Sharp, Richard [1 ]
Sprock, Joyce [1 ]
Braff, David [1 ]
Swerdlow, Neal [1 ]
Light, Gregory [3 ]
机构：
[1] Univ Calif San Diego, San Diego, CA 92103 USA
[2] Swartz Ctr Neural Computat UCSD, San Diego, CA USA
[3] Univ Calif San Diego, VA San Diego Healthcare Syst, La Jolla, CA 92093 USA
来源：
BIOLOGICAL PSYCHIATRY | 2022年 / 91卷 / 09期
关键词：
Schizophrenia; Anticholinergic Burden; MMN; P3A;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P605
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 50 条
  • [41] Emitted P3a and P3b in Chronic Schizophrenia and in First-Episode Schizophrenia-Spectrum Psychosis
    McCathern, Alexis G.
    Coffman, Brian A.
    Murphy, Timothy K.
    Ward, Kayla L.
    Haigh, Sarah
    Salisbury, Dean
    BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S80 - S80
  • [42] RELATION OF NEUROLEPTIC AND ANTICHOLINERGIC MEDICATION TO COGNITIVE FUNCTIONS IN SCHIZOPHRENIA
    SPOHN, HE
    STRAUSS, ME
    JOURNAL OF ABNORMAL PSYCHOLOGY, 1989, 98 (04) : 367 - 380
  • [43] CONTRIBUTION OF ANTICHOLINERGIC MEDICATION TO SYMPTOM CHANGE IN SCHIZOPHRENIA - REPLY
    SERBAN, G
    JOURNAL OF CLINICAL PSYCHIATRY, 1993, 54 (09) : 357 - 357
  • [44] The impact of hospitalisation on the anticholinergic burden in patients
    Prinsen, M.
    Leenders, T.
    Keyany, A.
    Arnoldussen, D.
    van Asseldonk, T.
    Maat, B.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (03) : 816 - 816
  • [45] Anticholinergic burden: Measurement and impact.
    Boustani, M. A.
    Limbil, T.
    Campbell, N.
    Fox, C.
    Maidment, I.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S52 - S53
  • [46] Impact of anticholinergic medication burden on mobility and falls in the lifestyle interventions and independence for elders (LIFE) study
    Squires, Patrick
    Pahor, Marco
    Manini, Todd
    Brown, Joshua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 639 - 640
  • [47] Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia
    Luykx, Jurjen J.
    Correll, Christoph U.
    Manu, Peter
    Tanskanen, Antti
    Hasan, Alkomiet
    Tiihonen, Jari
    Taipale, Heidi
    JAMA PSYCHIATRY, 2024, 81 (10) : 967 - 975
  • [48] Temporal and Spectral Properties of the Auditory Mismatch Negativity and P3a Responses in Schizophrenia
    Lundin, Nancy B.
    Burroughs, Leah P.
    Kieffaber, Paul D.
    Morales, Jaime J.
    O'Donnell, Brian F.
    Hetrick, William P.
    CLINICAL EEG AND NEUROSCIENCE, 2023, 54 (04) : 409 - 419
  • [49] P3a and real-life functioning in a sample of chronic schizophrenia subjects
    Giordano, G. M.
    Mucci, A.
    Vignapiano, A.
    Di Lorenzo, G.
    Ferrentino, F.
    Bellomo, A.
    Altamura, M.
    Galderisi, S.
    EUROPEAN PSYCHIATRY, 2019, 56 : S590 - S591
  • [50] Altered P3a Modulations to Emotional Faces in Male Patients With Chronic Schizophrenia
    Onitsuka, Toshiaki
    Spencer, Kevin M.
    Nakamura, Itta
    Hirano, Yoji
    Hirano, Shogo
    McCarley, Robert W.
    Shenton, Martha E.
    Niznikiewicz, Margaret A.
    CLINICAL EEG AND NEUROSCIENCE, 2020, 51 (04) : 215 - 221
12345